• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用穿透肽的选择性和靶向药物/基因传递系统的最新进展。

Recent advances in selective and targeted drug/gene delivery systems using cell-penetrating peptides.

机构信息

College of Pharmacy, Dongduk Women's University, Seoul, 02748, Republic of Korea.

Department of Medical Life Sciences and Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.

出版信息

Arch Pharm Res. 2023 Jan;46(1):18-34. doi: 10.1007/s12272-022-01425-y. Epub 2023 Jan 3.

DOI:10.1007/s12272-022-01425-y
PMID:36593377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9807432/
Abstract

Biological cell membranes are a natural barrier for living cells. In the last few decades, the cell membrane has been the main hurdle in the efficient delivery of bioactive and therapeutic agents. To increase the drug efficacy of these agents, additional mediators have been considered. Cell-penetrating peptides (CPPs), a series of oligopeptides composed of mostly hydrophobic and/or positively charged side chains, can increase the interaction with the cell membrane. CPP-based delivery platforms have shown great potential for the efficient and direct cytosol delivery of various cargos, including genes, proteins, and small molecule drugs. Bypassing endocytosis allows the CPP-based delivery systems greater defense against the degradation of protein-based drugs than other drug delivery systems. However, the delivery of CPPs exhibits intrinsically non-specific targeting, which limits their medical applications. To endow CPPs with specific targeting ability, the conjugation of pH-sensitive, enzyme-specific cleavable, and multiple targeting ligands has been reported. Optimization of the length and sequence of CPPs is still needed for various drugs of different sizes and surface charges. Toxicity issues in CPP-based delivery systems should be addressed carefully before clinical use.

摘要

生物细胞膜是活细胞的天然屏障。在过去的几十年中,细胞膜一直是生物活性和治疗剂有效传递的主要障碍。为了提高这些药物的疗效,人们考虑了其他的介导物。细胞穿透肽(CPPs)是由大多数疏水性和/或带正电荷的侧链组成的一系列寡肽,可以增加与细胞膜的相互作用。基于 CPP 的递药平台在有效和直接将各种载药(包括基因、蛋白质和小分子药物)递送到细胞质方面显示出巨大的潜力。绕过内吞作用使基于 CPP 的递药系统比其他递药系统具有更大的防御能力来抵抗基于蛋白质的药物的降解。然而,CPP 的递药表现出固有非特异性靶向性,这限制了它们的医学应用。为了赋予 CPP 特定的靶向能力,已经报道了 pH 敏感、酶特异性可切割和多靶向配体的缀合。对于不同大小和表面电荷的各种药物,还需要优化 CPP 的长度和序列。在临床应用之前,应仔细解决基于 CPP 的递药系统的毒性问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/5de328d9bd1f/12272_2022_1425_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/9eb14250451b/12272_2022_1425_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/c00272d4cb18/12272_2022_1425_Sch2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/9ca403a3808d/12272_2022_1425_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/adc76cfd5c7e/12272_2022_1425_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/21dd25a0b37e/12272_2022_1425_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/f01eac251972/12272_2022_1425_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/da66cb50969f/12272_2022_1425_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/41585ef13167/12272_2022_1425_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/3e44397fbd76/12272_2022_1425_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/5de328d9bd1f/12272_2022_1425_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/9eb14250451b/12272_2022_1425_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/c00272d4cb18/12272_2022_1425_Sch2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/9ca403a3808d/12272_2022_1425_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/adc76cfd5c7e/12272_2022_1425_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/21dd25a0b37e/12272_2022_1425_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/f01eac251972/12272_2022_1425_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/da66cb50969f/12272_2022_1425_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/41585ef13167/12272_2022_1425_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/3e44397fbd76/12272_2022_1425_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ffe/9807432/5de328d9bd1f/12272_2022_1425_Fig8_HTML.jpg

相似文献

1
Recent advances in selective and targeted drug/gene delivery systems using cell-penetrating peptides.利用穿透肽的选择性和靶向药物/基因传递系统的最新进展。
Arch Pharm Res. 2023 Jan;46(1):18-34. doi: 10.1007/s12272-022-01425-y. Epub 2023 Jan 3.
2
Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?穿膜肽的膜穿透和膜转导活性:危险的结合?
Acc Chem Res. 2017 Dec 19;50(12):2968-2975. doi: 10.1021/acs.accounts.7b00455. Epub 2017 Nov 27.
3
Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.膜电位依赖性细胞穿透肽转位孔的遗传、细胞和结构特征。
Elife. 2021 Oct 29;10:e69832. doi: 10.7554/eLife.69832.
4
Covalent conjugation and non-covalent complexation strategies for intracellular delivery of proteins using cell-penetrating peptides.利用穿膜肽实现蛋白质细胞内递送的共价偶联和非共价络合策略。
Biomed Pharmacother. 2024 Jul;176:116910. doi: 10.1016/j.biopha.2024.116910. Epub 2024 Jun 8.
5
Applications and Challenges for Use of Cell-Penetrating Peptides as Delivery Vectors for Peptide and Protein Cargos.细胞穿透肽作为肽和蛋白质货物递送载体的应用与挑战
Int J Mol Sci. 2016 Jan 30;17(2):185. doi: 10.3390/ijms17020185.
6
Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.利用穿透肽实现核酸药物的高效细胞内递送。
Acc Chem Res. 2012 Jul 17;45(7):1132-9. doi: 10.1021/ar200256e. Epub 2011 Dec 30.
7
Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.细胞穿透肽辅助药物递送的近期体内研究进展。
Expert Opin Drug Deliv. 2016;13(3):373-87. doi: 10.1517/17425247.2016.1125879. Epub 2015 Dec 22.
8
Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery.细胞穿透肽作为细胞内货物传递新载体的最新进展。
J Control Release. 2014 Jan 28;174:126-36. doi: 10.1016/j.jconrel.2013.11.020. Epub 2013 Dec 1.
9
The Current Role of Cell-Penetrating Peptides in Cancer Therapy.细胞穿透肽在癌症治疗中的当前作用
Adv Exp Med Biol. 2017;1030:279-295. doi: 10.1007/978-3-319-66095-0_13.
10
Cell-penetrating peptides: possibilities and challenges for drug delivery in vitro and in vivo.细胞穿透肽:体外和体内药物递送的可能性与挑战
Molecules. 2015 Jul 22;20(7):13313-23. doi: 10.3390/molecules200713313.

引用本文的文献

1
Characterization of holins, the membrane proteins of coliphage ASEC2201: a genomewide approach.大肠杆菌噬菌体ASEC2201的膜蛋白——穿孔素的特性:一种全基因组方法
Front Microbiol. 2025 Jul 9;16:1550594. doi: 10.3389/fmicb.2025.1550594. eCollection 2025.
2
Computational investigation of antiviral peptide interactions with Mpox DNA polymerase.抗病毒肽与猴痘病毒DNA聚合酶相互作用的计算研究
In Silico Pharmacol. 2025 Mar 28;13(1):49. doi: 10.1007/s40203-025-00342-4. eCollection 2025.
3
Peptides: potential delivery systems for mRNA.
肽:mRNA的潜在递送系统。
RSC Chem Biol. 2025 Feb 26;6(5):666-677. doi: 10.1039/d4cb00295d. eCollection 2025 May 8.
4
Applications of cell penetrating peptide-based drug delivery system in immunotherapy.基于细胞穿透肽的药物递送系统在免疫治疗中的应用。
Front Immunol. 2025 Jan 22;16:1540192. doi: 10.3389/fimmu.2025.1540192. eCollection 2025.
5
Emerging Nanoparticle-Based Diagnostics and Therapeutics for Cancer: Innovations and Challenges.新兴的基于纳米颗粒的癌症诊断与治疗:创新与挑战
Pharmaceutics. 2025 Jan 7;17(1):70. doi: 10.3390/pharmaceutics17010070.
6
Enhancing RNA inhibitory activity using clamp-G-modified nucleobases.使用钳形-G修饰的核碱基增强RNA抑制活性。
Cell Rep Phys Sci. 2024 Aug 21;5(8). doi: 10.1016/j.xcrp.2024.102120. Epub 2024 Jul 29.
7
Lysosome-targeting chimeras containing an endocytic signaling motif trigger endocytosis and lysosomal degradation of cell-surface proteins.含有内吞信号基序的溶酶体靶向嵌合体可触发细胞表面蛋白的内吞作用和溶酶体降解。
Chem Sci. 2024 Oct 1;15(42):17652-62. doi: 10.1039/d4sc05093b.
8
Upgrading Mitochondria-Targeting Peptide-Based Nanocomplexes for Zebrafish In Vivo Compatibility Assays.升级用于斑马鱼体内相容性测定的线粒体靶向肽基纳米复合物。
Pharmaceutics. 2024 Jul 20;16(7):961. doi: 10.3390/pharmaceutics16070961.
9
Advanced gene nanocarriers/scaffolds in nonviral-mediated delivery system for tissue regeneration and repair.高级基因纳米载体/支架在非病毒介导的组织再生和修复递药系统中的应用。
J Nanobiotechnology. 2024 Jun 26;22(1):376. doi: 10.1186/s12951-024-02580-8.
10
Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma.肽搭乘用于神经胶质瘤中纳米系统的发展。
ACS Nano. 2024 Jul 2;18(26):16359-16394. doi: 10.1021/acsnano.4c01790. Epub 2024 Jun 11.